Lantheus Holdings (LNTH) Interest Expenses (2014 - 2026)

Lantheus Holdings' (LNTH) quarterly Interest Expenses came in at $49.0 million in Q1 2026, up 107.0% year-on-year from $23.7 million in Q1 2025, and up 865.75% on a QoQ basis from $5.1 million in Q4 2025.

Lantheus Holdings (LNTH) Interest Expenses (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has 13 years of Interest Expenses data on file, last reported at $49.0 million in Q1 2026.

  • On a quarterly basis, Interest Expenses rose 107.0% year-over-year to $49.0 million in Q1 2026; TTM through Mar 2026 was $49.0 million, a 107.0% increase from a year earlier, with the FY2025 full-year figure at $180.5 million, down 99.49% from the prior year.
  • Interest Expenses for Q1 2026 stood at $49.0 million, up from $5.1 million in the prior quarter.
  • Over the last five years, Interest Expenses for LNTH reached as high as $57.9 million in Q3 2025 and fell as low as $460000.0 in Q4 2022.
  • Historically, Interest Expenses has averaged $22.5 million across 5 years, with a median of $23.6 million in 2025.
  • Across the five-year window, Interest Expenses tumbled 75.09% in 2024 and jumped 1081.52% in 2025, its largest moves.
  • Year by year, Interest Expenses stood at $460000.0 in 2022, then soared by 995.87% to $5.0 million in 2023, then advanced by 0.08% to $5.0 million in 2024, then gained by 0.65% to $5.1 million in 2025, then soared by 865.75% to $49.0 million in 2026.
  • Per Business Quant data, the three most recent Interest Expenses figures were $49.0 million in Q1 2026, $5.1 million in Q4 2025, and $57.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 62.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 944.51 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 1.77 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 2.17 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.21 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 590.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 57.00 Mn
10 Lantheus Holdings 6.72 Bn 6.22 Bn 230.92 Mn 49.04 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 49.04 Mn
Mar 31, 2026 49.04 Mn
Dec 31, 2025 5.08 Mn
Dec 31, 2025 5.08 Mn
Sep 30, 2025 57.93 Mn
Sep 30, 2025 57.93 Mn
Jun 30, 2025 23.65 Mn
Jun 30, 2025 23.65 Mn
Mar 31, 2025 23.69 Mn
Mar 31, 2025 23.69 Mn
Dec 31, 2024 5.05 Mn
Dec 31, 2024 5.05 Mn
Sep 30, 2024 4.90 Mn
Sep 30, 2024 4.90 Mn
Jun 30, 2024 21.95 Mn
Jun 30, 2024 21.95 Mn
Mar 31, 2024 16.20 Mn
Mar 31, 2024 16.20 Mn
Dec 31, 2023 5.04 Mn
Dec 31, 2023 5.04 Mn